To compare clinical association of BIRC5/survivin protein levels and the expression of its mRNA, we took advantage of the mRNA levels of samples for the independent well-characterized BC cohorts, METABRIC [34], and SCAN-B (Table 1, Figure 1C) [35]. This evidence concerns the gene BIRC5 and breast cancer.